Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTime Inc (NYSE American:BTX)

2.66
Delayed Data
As of 6:30pm ET
 +0.02 / +0.76%
Today’s Change
2.10
Today|||52-Week Range
3.62
+23.72%
Year-to-Date
No recent news for BioTime Inc.

Today’s Trading

Previous close2.64
Today’s open2.63
Day’s range2.61 - 2.68
Volume326,969
Average volume (3 months)394,375
Market cap$334.9M
Data as of 6:30pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2.94%
Earnings growth (next 5 years)--
Revenue growth (last year)-15.82%
P/E ratio6.3
Price/Sales60.68
Price/Book2.30

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp-0.03-1.49%
EDGEEdge Therapeutics In...+0.31+3.00%
AGENAgenus Inc+0.13+3.43%
BLCMBellicum Pharmaceuti...-0.01-0.12%
Data as of 4:00pm ET, 01/17/2018

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$5.9M
Annual profit (last year)$33.6M
Net profit margin566.81%

Profile

Sector
Health Technology
Industry
Medical Specialties
Co-Chief Executive Officer &
Director
Michael D. West
President, Co-Chief Executive Officer &
Director
Adi Mohanty
Corporate headquarters
Alameda, California

Forecasts